Home/Firalis/Dr. Beatrice Molac
DB

Dr. Beatrice Molac

Director of Intellectual Property and Regulatory Affairs

Firalis

Firalis Pipeline

DrugIndicationPhase
Cardiovascular Biomarkers R&DCardiovascular DiseasesDevelopment
Neurodegenerative Biomarkers R&DNeurodegenerative DiseasesDevelopment
Drug-Induced Organ Injury BiomarkersKidney, Liver, Vascular ToxicityDevelopment
Inflammatory Disorder Biomarkers (e.g., RA, Vasculitis)Rheumatoid Arthritis, Autoimmune VasculitisDevelopment